Henry Schein (NASDAQ:HSIC) Rating Lowered to “Hold” at Wall Street Zen

Henry Schein (NASDAQ:HSIC) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday.

A number of other analysts have also weighed in on HSIC. Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective on the stock in a research report on Tuesday, August 26th. Stifel Nicolaus restated a “hold” rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 6th. Baird R W downgraded shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Finally, Robert W. Baird restated a “neutral” rating and issued a $72.00 target price (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Five analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $76.67.

Henry Schein Stock Performance

Henry Schein stock opened at $63.17 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The firm has a market capitalization of $7.66 billion, a P/E ratio of 20.38, a price-to-earnings-growth ratio of 2.08 and a beta of 0.81. The company’s 50-day moving average is $67.48 and its 200 day moving average is $68.80.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same period last year, the company earned $1.23 earnings per share. The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Research analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Hedge Funds Weigh In On Henry Schein

Hedge funds and other institutional investors have recently modified their holdings of the business. UMB Bank n.a. boosted its stake in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after acquiring an additional 201 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Henry Schein by 237.3% in the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after acquiring an additional 1,898 shares in the last quarter. GAMMA Investing LLC boosted its stake in Henry Schein by 37.8% in the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after acquiring an additional 1,081 shares in the last quarter. Simon Quick Advisors LLC acquired a new stake in Henry Schein in the first quarter valued at approximately $225,000. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in Henry Schein by 0.5% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company’s stock valued at $3,639,000 after acquiring an additional 243 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.